OTC Markets OTCPK - Delayed Quote USD

Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF)

0.6484 -0.8516 (-56.77%)
At close: April 1 at 9:30 AM EDT
Loading Chart for BJTRF
DELL
  • Previous Close 1.5000
  • Open 0.6484
  • Bid --
  • Ask --
  • Day's Range 0.6484 - 0.6484
  • 52 Week Range 0.6484 - 1.5000
  • Volume 400
  • Avg. Volume 12
  • Market Cap (intraday) 1.061B
  • Beta (5Y Monthly) 0.38
  • PE Ratio (TTM) 8.11
  • EPS (TTM) 0.0800
  • Earnings Date Mar 14, 2024
  • Forward Dividend & Yield 0.04 (6.51%)
  • Ex-Dividend Date Jun 12, 2024
  • 1y Target Est --

Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals. The company operates through three segments: Hong Kong, Mainland China, and Overseas. It also offers Chinese medical consultation and treatment services. The company operates retail outlets in Hong Kong and in other countries and regions in Asia, Oceania, North America, and Europe. It markets its products under the Tong Ren Tang brand. Beijing Tong Ren Tang Chinese Medicine Company Limited was founded in 1669 and is based in Wan Chai, Hong Kong.

www.tongrentangcm.com

798

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BJTRF

Performance Overview: BJTRF

Trailing total returns as of 6/7/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BJTRF
56.48%
HANG SENG INDEX
7.74%

1-Year Return

BJTRF
56.48%
HANG SENG INDEX
3.83%

3-Year Return

BJTRF
17.29%
HANG SENG INDEX
36.49%

5-Year Return

BJTRF
56.48%
HANG SENG INDEX
36.90%

Compare To: BJTRF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BJTRF

Valuation Measures

Annual
As of 6/7/2024
  • Market Cap

    1.06B

  • Enterprise Value

    773.46M

  • Trailing P/E

    7.79

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.78

  • Price/Book (mrq)

    1.10

  • Enterprise Value/Revenue

    3.96

  • Enterprise Value/EBITDA

    7.78

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    35.44%

  • Return on Assets (ttm)

    8.98%

  • Return on Equity (ttm)

    15.22%

  • Revenue (ttm)

    1.52B

  • Net Income Avi to Common (ttm)

    540.39M

  • Diluted EPS (ttm)

    0.0800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.4B

  • Total Debt/Equity (mrq)

    3.28%

  • Levered Free Cash Flow (ttm)

    317.64M

Research Analysis: BJTRF

Company Insights: BJTRF

Research Reports: BJTRF

People Also Watch